Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-02-12 00:00:00 ET · period of report 2025-02-10 · accession 0001415889-25-003748 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-12 | 2025-02-10 | KNSA | Tessari Eben | COO | M - OptEx | $3.80 | +7,000 | 96.0K | +8% | +$26.6K |
| D | 2025-02-12 | 2025-02-10 | KNSA | Tessari Eben | COO | S - Sale+OE | $19.57 | -14.0K | 82.0K | -15% | -$274.0K |
| D | 2025-02-12 | 2025-02-10 | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -7,000 | 21.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-02-10 | M | A | 7,000 | $3.80 | 95,975 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-02-10 | S | D | 14,000 | $19.57 | 81,975 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $19.395 and $19.87. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Derivative | Share Option | 2025-02-10 | M | D | 7,000 | $0.00 | 21,049 | D | $3.80 · — to 2027-06-28 | 7,000 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |